The anticryptococcal activity of murine bronchoalveolar macrophages (BAM) and their synergy with fluconazole (FCZ) was studied. BAM cultured with tissue culture medium for 48 to 72 h were fungicidal (24 to 39%o) in a 3-h killing assay. However, net killing of Cryptococcus neoformans did not continue when culture time was extended to 24 h, although BAM were fungistatic (88 to 98%). Treatment with macrophage colony-stimulating factor (M-CSF; 5,000 U/ml, 48 h) did not significantly increase BAM killing of a low challenge dose in 3-h assays compared with control BAM. However, M-CSF-treated BAM were significantly more fungistatic against higher challenge doses in the 3-h assays. FCZ was not fungicidal at 5 ,ug/ml but was highly fungistatic (98 and 99%o at 24 and 48 h, respectively). M-CSF-treated BAM acted synergistically with FCZ (2.5 ,uglml) for significantly greater killing than control BAM, 55% versus 20%01 and 96% versus 45% at 24 h and 48 h, respectively. Killing by M-CSF BAM and FCZ (5.0 pug/ml) was significantly (P < 0.01) greater than that by control BAM and FCZ at 48 h. These findings indicate an important collaborative role for BAM and FCZ in killing C. neoformans, and this is enhanced by M-CSF.
(408) 998-2723. patients (22) . Here, we report the effect of M-CSF on BAM anticryptococcal activity and synergy with FCZ for killing C. neoformans.
MATERUILS AND METHODS
Mice. Young adult male mice, 8 to 12 weeks old, were used as sources of serum and BAM. Outbred CD-1 mice were purchased from Charles River Laboratories, Wilmington, Mass., and inbred BALB/c/An/N/Sim (referred to hereafter as BALB/c) mice were supplied by Simonsen Laboratories, Gilroy, Calif BAM. Mice anesthetized with ethyl ether were exsanguinated by severing of the brachial artery. Blood was collected as a source of fresh mouse serum. After cervical dislocation, pulmonary lavage was performed as described by Sugar et al. (21) . Briefly, 10 ml of phosphate-buffered saline with 0.1% EDTA (free acid) adjusted to pH 7.4 was used to lavage the lungs of each mouse. Cells were pelleted by centrifugation (225 x g, 10 min). Pelleted cells from five or more mice were pooled, washed, and counted. Cells were suspended in complete tissue culture medium (CTCM) consisting of RPMI 1640, 10% (vol/vol) heat-inactivated fetal bovine serum, and penicillin (100 U/ml) plus streptomycin (100 ,ug/ml). Cells at 1.5 x 106/ml of CTCM were dispensed at 0.1 ml per well of an A/2 microtest plate (Costar, Cambridge, Mass.). After 2 h at 37°C with 5% CO2 plus 95% air, nonadherent cells were aspirated and adherent cell monolayers (BAM) were washed once with RPMI 1640. Approximately 90% of plated cells were adherent and had alveolar macrophage morphology.
C. neoformans. Three encapsulated isolates of C. neofornans were used in these studies. The capsule thickness ranged from 1.0 to 1.3 jim. Susceptibility testing performed by broth dilution methods previously described (13) Treatment of BAM. BAM monolayers were treated with CTCM or 5,000 U of human recombinant M-CSF (Genetics Inst., Cambridge, Mass.; 1.9 x 106 U/mg) per ml for increasing periods of time.
Fungicidal and fungistatic assays. BAM cultured in CTCM or M-CSF were challenged with 0.1 ml of C. neofornans in CTCM plus 10% fresh mouse serum for 3 h in a fungicidal assay. At time zero, the inoculum was plated to determine the number of CFU per well. After the 3 h at 37°C in 5% CO2 plus 95% air, the control culture (yeast cells alone) and the experimental macrophage cocultures were harvested with distilled water to lyse macrophages. Dilutions of harvested material were plated on blood agar plates, and CFU were counted after 48 h at 35°C. Microscopic examination of microtest plate wells verified the removal of macrophages from the wells. Microscopic examination of the harvested material showed that the macrophages were lysed and there was no clumping of yeast cells. The percent fungicidal activity was determined as [1 - (experimental CFU/inoculum CFU)] x 100. The same procedure was used in 24-h fungistatic assays, and percent fungistasis was calculated as [1 - (experimental CFU/CFU in 24-h CTCM)] x 100.
Fungicidal mechanisms. Superoxide and hydrogen peroxide scavengers, superoxide dismutase and catalase (Sigma Chemical Co., St. Louis, Mo.), were used to see if killing was mediated by products of the oxidative burst. Reagents were prepared, and concentrations were used as previously reported (5, 7). NG-monomethyl-L-arginine (NMMA) was used as the competitive analog inhibitor of L-arginine, the substrate for the production of nitric oxide by activated macrophages (6, 8) .
Statistics. Comparison between groups was made by Student's t test with the significance set at P < 0.05.
RESULTS
Elfect of culture time on BAM fungicidal activity. BAM from BALB/c mice cultured for 24 h in CTCM or M-CSF (5,000 U/ml) were not fungicidal against C. neofornans in a 3-h assay. However, after 48 h of culture in CTCM or M-CSF (5,000 U/ml), BAM killed yeast cells at 24 (P < 0.01) and 45% (P < 0.001), respectively ( Fig. 1 ). M-CSF BAM were significantly (P < 0.05) more fungicidal than CTCM BAM in this experiment ( Fig. 1 ). When BAM were cultured for 72 h in CTCM or M-CSF (5,000 U/ml), they did not have significantly increased fungicidal activity.
Effect of culture time on fungistatic activity of BAM. BALB/c BAM cultured for 24 h in CTCM or M-CSF (5,000 U/ml) and then challenged for 24 h significantly (P < 0.001) and equally inhibited the growth of C. neoformans (Fig. 2) . Fungistatic activity was significantly increased (P < 0.001) if BAM were cultured for 48 h in CTCM or M-CSF before challenge, to 98 and 99%, respectively (Fig. 2) . If culture time was extended to 72 h before challenge, fungistasis of CTCM BAM did not significantly change; however, M-CSF BAM were then fungicidal in the 24-h assay (Fig. 2) . cidal, at 21 (P < 0.01) and 30% (P < 0.001), respectively, against the low inoculum (Fig. 3) . When the challenge dose was increased threefold, there was no significant killing by CTCM or M-CSF BAM; however, both had significant fungistasis (P < 0.01) (Fig. 3) . At the highest challenge dose, eight times the lowest dose, CTCM BAM were still fungistatic (P < 0.05) and M-CSF BAM were modestly fungicidal (17%, P < 0.01) (data not shown). Fungicidal mechanisms. The presence of superoxide dismutase (500 U/ml) or catalase (20,000 U/ml) during the 3-h fungicidal assay did not inhibit killing (29%) by M-CSF BALB/c BAM. The presence of NMMA (0.2 mM) during the killing assay also had no effect on killing. These results suggest that killing was not mediated by products of the oxidative burst or generation of nitric oxide in this time frame. Effects of mouse strain and C. neoformans isolate on killing In 48-h cultures, M-CSF BAM were more fungistatic than CI1CM BAM (98% versus 66%, P < 0.001). Moreover, M-CSF BAM had a greater synergy with FCZ at 2.5 ,ug/ml than did CTCM BAM for killing (96% versus 29%, P < 0.01) ( Table 2) . The same was true for M-CSF BAM versus CTCM BAM with FCZ at 5.0 ,ug/ml (96% versus 80% killing, P < 0.01) ( Table 2 ). These findings indicate that M-CSF significantly enhances BAM fungistasis and synergy with FCZ for killing.
Results similar to those above were obtained in a second experiment. For example, M-CSF BAM were significantly more fungistatic against C. neoformans CDC 9759 than were CTCM-cultured BAM at 24 and 48 h (P < 0.001). Killing by BAM plus FCZ (5.0 ,ug/ml) significantly increased from 50% in 24 h to 92% in 48 h (P < 0.001). Killing by M-CSF BAM plus FCZ (5.0 ,ug/ml) also significantly increased from 76% at 24 h to 94% at 48 h (P < 0.001).
Failure of BAM and FCZ to kill isolate 92-197. CTCM and M-CSF BALB/c BAM were fungistatic against isolate 92-197, at 73 and 94%, respectively, in 48-h cocultures. FCZ at 10 jig/ml was 99% fungistatic in 48-h cultures. BAM and M-CSF BAM in the presence of FCZ (10 ,ug/ml) had significantly (P < 0.001) increased fungistasis compared with FCZ alone, e.g., 2,720 ± 120 CFU (BAM) and 1,570 + 80 CFU (M-CSF BAM) compared with 6,000 + 800 CFU (FCZ alone). Moreover, M-CSF BAM plus FCZ was significantly (P < 0.001) more fungistatic than BAM plus FCZ, i.e., 1,540 ± 80 CFU versus 2,720 ± 120 CFU, respectively. However, there was no killing, i.e., reduction of inoculum CFU (715 ± 118 CFU), with these combinations in 48 h.
DISCUSSION
The modest killing of C. neoformans by BAM from outbred CD-1 mice reported here is similar to that found by Levitz and DiBenedetto (14) . The fungicidal activity of BAM against C. neoformans noted here is similar to the killing of Candida parapsilosis by BAM (4) . By contrast, killing activity by BAM against Candida albicans is only slight in this system.
BAM from inbred BALB/c mice were fungicidal against C. neoformans after being cultured in tissue culture medium for 2 to 3 days. We speculate that adherence, factors in culture medium, and M-CSF endogenously produced by BAM medium. In previous work, we found that peritoneal macrophages, but not BAM, could be activated by gamma interferon in 24 h for killing of C. albicans. However, BAM could be activated to kill C. albicans by supernatants from concanavalin A-stimulated spleen cells (4). The BAM-activating factor(s) in concanavalin A supernatants have not been identified. Significant fungicidal activity of BAM was found to be dependent on a high BAM-to-yeast cell ratio. This is a situation likely to be found in a natural pulmonary exposure. Furthermore, we found as did others that the fungicidal activity of BAM against C. neoformans did not depend on products of the oxidative burst or on nitric oxide production (14) .
Even though BAM were only modestly fungicidal against C. neoformans, they were strongly fungistatic against surviving yeast cells in 24-h assays. In this respect, BAM activities were similar to the anticryptococcal activity of human alveolar macrophages (24). M-CSF could significantly enhance the fungistatic activity of BAM compared with control BAM. It remains to be seen if M-CSF could have a similar effect on human alveolar macrophages.
BAM from CD-1 and BALB/c mice cultured for 3 days in tissue culture medium or M-CSF had similar fungicidal activities against isolates of C. neoformnans. Both M-CSF and control BAM killed the more slowly growing isolate W more efficiently than the faster-growing CDC 9759 isolate. Although lower growth rate correlated with susceptibility, it is possible that other characteristics of isolate W were responsible for greater susceptibility. Others have found an association between greater encapsulation and enhanced killing of opsonized C. neoformans by BAM (14) . Both isolates tested here had medium-sized capsules; therefore, differences in susceptibility were not due to capsule size.
FCZ at pharmacological concentrations is only fungistatic against C. neoformans in vitro. However, we show here that these concentrations of FCZ synergize with fungistatic BAM for efficient killing of C. neoformans. FCZ can also act synergistically with peritoneal macrophages for killing FCZ-sensitive isolates of C. neoformans (6) . These findings suggest an explanation for the in vivo efficacy of FCZ in cryptococcosis. The synergistic mechanism by which C. neoformans is killed is not known at this time.
On the other hand, BAM and peritoneal macrophages (6) cannot synergize with an FCZ-resistant isolate for killing. These findings suggest a possible new relevance for susceptibility testing of C. neoformans isolates.
Since M-CSF enhances macrophage fungistasis and synergy with FCZ in killing C. neoformans, therapeutic applications of M-CSF as an adjunct to antifungal therapy merit consideration.
